Interestingly, TP53 mutations are particularly frequent in basal‐like breast cancer and can be found in over 80% of cases, whereas in non‐basal tumors, they are significantly less common (Sorlie et al, 2001; Cancer Genome Atlas Network, 2012). This evidence concerns the gene TP53 and breast carcinoma.